| [February 14, 2012] |
 |
MetLife Announces Fourth Quarter and Full Year 2011 Results
NEW YORK --(Business Wire)--
MetLife, Inc. (NYSE: MET) today reported fourth quarter 2011 net income
of $1.1 billion, or $1.06 per share, and operating earnings1
of $1.4 billion, or $1.31 per share. MetLife today also reported full
year 2011 net income of $6.7 billion, or $6.29 per share, and operating
earnings of $5.4 billion, or $5.02 per share.
"MetLife had a solid year and a strong fourth quarter, even in the face
of some significant market pressures," said Steven A. Kandarian,
chairman, president and chief executive officer of MetLife, Inc. "We
delivered higher earnings per share over 2010. Our capital position is
strong and getting stronger. And our ability to grow operating earnings
in the face of low interest rates remains intact. In short, we think
we're the best-positioned company in the life insurance sector to
deliver shareholder value."
|
___________
|
|
1 Information regarding the non-GAAP financial measures
included in this press release and the reconciliation of them to
GAAP measures are provided in the Non-GAAP and Other Financial
Disclosures discussion below, as well as in the tables that
accompany this release and/or the Fourth Quarter 2011 Quarterly
Financial Supplement.
|
|
|
FULL YEAR 2011 SUMMARY
-
Operating earnings of $5.4 billion, or $5.02 per share, up 40% over
2010
-
Premiums, fees & other revenues of $45.7 billion, up 32% over 2010
-
Total assets of nearly $800 billion, up 9% from year-end 2010
|
|
|
|
|
|
($ in millions, except per share data)
|
|
|
For the year ended December 31,
|
|
|
|
|
|
2011
|
|
|
|
2010
|
|
|
Change
|
|
Premiums, fees & other revenues
|
|
|
$
|
45,708
|
|
|
$
|
34,563
|
|
|
32%
|
|
Total operating revenues
|
|
|
$
|
65,384
|
|
|
$
|
51,443
|
|
|
27%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
$
|
6,713
|
|
|
$
|
2,668
|
|
|
-
|
|
Net income per share
|
|
|
$
|
6.29
|
|
|
$
|
3.00
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
|
$
|
5,358
|
|
|
$
|
3,833
|
|
|
40%
|
|
Operating earnings per share
|
|
|
$
|
5.02
|
|
|
$
|
4.31
|
|
|
16%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FOURTH QUARTER 2011 SUMMARY
-
Operating earnings of $1.4 billion, or $1.31 per share, up 17% over
the fourth quarter of 2010
-
Total International sales up 12% compared with combined MetLife and
Alico fourth quarter 2010 results
-
Premiums, fees & other revenues of $11.5 billion, up 23% over the
fourth quarter of 2010, largely due to the acquisition of Alico as
well as growth in the U.S.
-
Book value per share of $54.59, up 24% from year-end 2010
|
|
|
|
|
|
($ in millions, except per share data)
|
|
|
For the three months ended December 31,
|
|
|
|
|
|
2011
|
|
|
|
2010
|
|
|
Change
|
|
Premiums, fees & other revenues
|
|
|
$
|
11,498
|
|
|
$
|
9,325
|
|
|
23%
|
|
Total operating revenues
|
|
|
$
|
16,405
|
|
|
$
|
13,762
|
|
|
19%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
$
|
1,125
|
|
|
$
|
51
|
|
|
-
|
|
Net income per share
|
|
|
$
|
1.06
|
|
|
$
|
0.05
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings
|
|
|
$
|
1,398
|
|
|
$
|
1,194
|
|
|
17%
|
|
Operating earnings per share
|
|
|
$
|
1.31
|
|
|
$
|
1.18
|
|
|
11%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per share
|
|
|
$
|
54.59
|
|
|
$
|
44.18
|
|
|
24%
|
|
Book value per share, excluding AOCI
|
|
|
$
|
49.02
|
|
|
$
|
43.23
|
|
|
13%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BUSINESS DISCUSSIONS
On November 21, 2011, MetLife announced it was reorganizing into three
broad geographic regions - The Americas, EMEA (Europe, the Middle East
and Africa) and Asia - to better reflect the company's global reach.
MetLife expects to report financial results under this new structure
beginning with the first quarter of 2012.
During the fourth quarter of 2011, MetLife began reporting certain
operations of MetLife Bank and insurance operations in the Caribbean
Region, Panama and Costa Rica as divested businesses. These operations
are excluded from operating earnings as well as investment portfolio and
derivative gains and losses. Prior periods have been reclassified to
conform with the current period segment presentation.
All comparisons of fourth quarter 2011 results in the business
discussions that follow are with the fourth quarter of 2010, unless
otherwise noted. Reconciliations of segment net income to segment
operating earnings are provided in the tables that accompany this
release and in the Fourth Quarter 2011 Quarterly Financial Supplement,
which is available on the Investor Relations section of www.metlife.com.
U.S. BUSINESS
-
U.S. Business operating earnings of $932 million, up 4%; the annual
review of deferred policy acquisition costs ("DAC") assumptions and
other adjustments resulted in a net $27 million, or $0.03 per share,
after tax, increase in U.S. Business operating earnings
-
Favorable underwriting results in group life and continued improvement
in non-medical health underwriting, particularly in the dental business
-
Variable annuity sales of $7.2 billion
-
Premiums, fees & other revenues of $7.6 billion, up 7% primarily due
to growth in Retirement Products and Corporate Benefit Funding
Insurance Products
Operating earnings for Insurance Products - which includes group life,
individual life and non-medical health insurance - were $411 million, up
33% largely due to the positive impact of DAC and other adjustments in
individual life as well as favorable underwriting results in group life
and non-medical health. Premiums, fees & other revenues for Insurance
Products were $5.1 billion, relatively unchanged.
Retirement Products
Operating earnings for Retirement Products - which includes the
company's U.S. annuity products - were $216 million, down 5% due to the
negative impact of DAC and other adjustments as well as lower variable
investment income, offset by growth from strong positive net flows and
higher core spreads. Compared with the fourth quarter of 2010 and the
third quarter of 2011, total annuity sales increased 41% and declined
15%, respectively, primarily due to a change in the level of variable
annuity sales. Premiums, fees & other revenues for Retirement Products
were $1.0 billion, up 35% due to increased sales of immediate annuities
and higher fee income.
Corporate Benefit Funding
Operating earnings for Corporate Benefit Funding - which includes the
U.S. and U.K. pension closeout businesses, structured settlements and
other benefit funding products - were $224 million, down 21% primarily
due to lower variable investment income. Premiums, fees & other revenues
for Corporate Benefit Funding were $739 million, up 44% largely due to
higher pension closeout sales (which often fluctuate significantly from
quarter to quarter).
Auto & Home
Operating earnings for Auto & Home were $81 million, up 9% due mainly to
lower catastrophes. In addition, favorable non-catastrophe claim
development related to prior accident years was $14 million, or $0.01
per share, after tax, compared with $16 million, after tax, in the
fourth quarter of 2010. Excluding catastrophes, Auto & Home's combined
ratio remained strong at 90.2%, compared with 90.0%. Net written
premiums were $740 million, up 2%.
INTERNATIONAL BUSINESS
-
International operating earnings of $570 million, up 89% largely due
to the acquisition of Alico2
-
Total International sales up 12% compared with combined MetLife and
Alico fourth quarter 2010 results
-
Premiums, fees & other revenues of $3.8 billion, reflecting growth in
Latin America, Eastern Europe and the Middle East as well as the
negative impact of foreign currency exchange rates
Japan
Operating earnings in Japan were $326 million, up 3% over the third
quarter of 2011 largely due to higher net investment income and both
solid underwriting results and improved persistency in accident and
health insurance. Compared with combined MetLife and Alico results in
the fourth quarter of 2010, sales grew 16%. Premiums, fees & other
revenues in Japan were $1.8 billion, higher than in the fourth quarter
of 2010 (which reflected only one month of Alico results) and relatively
unchanged from the third quarter of 2011.
Other International Regions
Operating earnings in the Other International Regions were $244 million,
up 17%, while premiums, fees & other revenues grew to $2.0 billion. The
increases, which were largely due to the Alico acquisition, were
partially offset by the negative impact of foreign currency exchange
rates. In addition, in Latin America, premiums, fees & other revenues
grew due to premium increases in Mexico, Chile and Argentina. Premiums,
fees & other revenues also benefited from strong performance in the
Middle East and Eastern Europe.
2MetLife acquired Alico on November 1, 2010. Accordingly,
Alico's financial results prior to that date are not reflected in
MetLife's historical financial statements.
CORPORATE & OTHER
Corporate & Other had an operating loss of $104 million, compared with
an operating loss of $2 million. Results in the fourth quarter of 2010
benefited from several one-time items, while the fourth quarter of 2011
was impacted by higher expenses.
INVESTMENTS
Net investment income was $4.9 billion, up 11% from the fourth quarter
of 2010 and down slightly from the third quarter of 2011. During the
fourth quarter of 2011, variable investment income was within the plan
range at $247 million ($162 million, after tax and the impact of DAC).
In the fourth quarter of 2010, variable investment income was $423
million ($268 million, after tax and the impact of DAC).
For the fourth quarter of 2011, MetLife reported a $213 million, after
tax, investment portfolio net loss compared with an investment portfolio
net gain of $6 million, after tax.
Separately, MetLife reported derivative net gains of $351 million, after
tax, which were largely due to declines in interest rates and gains in
the company's variable annuity hedging program. In the fourth quarter of
2010, MetLife reported $1.1 billion, after tax, in derivative net
losses. MetLife uses derivatives in connection with its broader
portfolio management strategy to hedge a number of risks, including
changes in interest rates and fluctuations in foreign currencies.
Movement in interest rates, foreign currencies and MetLife's credit
spreads - which impact the valuation of certain insurance liabilities -
can generate derivative gains or losses. Derivative gains or losses
related to MetLife's credit spreads do not have an economic impact on
the company.
Conference Call
MetLife will hold its fourth quarter and full year 2011 earnings
conference call and audio Webcast on Wednesday, February 15, 2012, from
8:00 to 9:00 a.m. (ET). The conference call will be available live via
telephone and the Internet. To listen over the telephone, dial (612)
326-1027 (domestic and international callers). To listen to the
conference call over the Internet, visit www.metlife.com
(through a link on the Investor Relations page). Those who want to
listen to the call on the telephone or via the Internet should dial in
or go to the Web site at least fifteen minutes prior to the call to
register, and/or download and install any necessary audio software.
The conference call will be available for replay via telephone and the
Internet beginning at 10:00 a.m. (ET) on Wednesday, February 15, 2012,
until Wednesday, February 22, 2012 at 11:59 p.m. (ET). To listen to a
replay of the conference call over the telephone, dial (320) 365-3844
(domestic and international callers). The access code for the replay is
226299. To access the replay of the conference call over the Internet,
visit the above-mentioned Web site.
About MetLife
MetLife, Inc. is a leading global provider of insurance, annuities and
employee benefit programs, serving 90 million customers in over 50
countries. Through its subsidiaries and affiliates, MetLife holds
leading market positions in the United States, Japan, Latin America,
Asia Pacific, Europe and the Middle East. For more information, visit www.metlife.com.
Non-GAAP and Other Financial Disclosures
All references in this press release (except in this section) to net
income (loss), net income (loss) per share, operating earnings,
operating earnings per share, book value per share, and premiums, fees
and other revenues, should be read as net income (loss) available to
MetLife, Inc.'s common shareholders, net income (loss) available to
MetLife, Inc.'s common shareholders per diluted common share, operating
earnings available to common shareholders, operating earnings available
to common shareholders per diluted common share, book value per common
share, and premiums, fees and other revenues (operating), respectively.
Operating earnings is the measure of segment profit or loss that MetLife
uses to evaluate segment performance and allocate resources. Consistent
with accounting principles generally accepted in the United States of
America ("GAAP") accounting guidance for segment reporting, operating
earnings is MetLife's measure of segment performance. Operating earnings
is also a measure by which MetLife senior management's and many other
employees' performance is evaluated for the purposes of determining
their compensation under applicable compensation plans.
Operating earnings is defined as operating revenues less operating
expenses, both net of income tax. Operating earnings available to common
shareholders is defined as operating earnings less preferred stock
dividends.
Operating revenues and operating expenses exclude results of
discontinued operations and other businesses that have been or will be
sold or exited by MetLife ("Divested Businesses"). Operating revenues
also excludes net investment gains (losses) ("NIGL") and net derivative
gains (losses) ("NDGL").
The following additional adjustments are made to GAAP revenues, in the
line items indicated, in calculating operating revenues:
-
Universal life and investment-type product policy fees excludes the
amortization of unearned revenue related to NIGL and NDGL and certain
variable annuity guaranteed minimum income benefits ("GMIB") fees
("GMIB Fees");
-
Net investment income: (i) includes amounts for scheduled periodic
settlement payments and amortization of premium on derivatives that
are hedges of investments but do not qualify for hedge accounting
treatment, (ii) includes income from discontinued real estate
operations, (iii) excludes post-tax operating earnings adjustments
relating to insurance joint ventures accounted for under the equity
method, (iv) excludes certain amounts related to
contractholder-directed unit-linked investments, and (v) excludes
certain amounts related to securitization entities that are variable
interest entities ("VIEs") consolidated under GAAP; and
-
Other revenues are adjusted for settlements of foreign currency
earnings hedges.
The following additional adjustments are made to GAAP expenses, in the
line items indicated, in calculating operating expenses:
-
Policyholder benefits and claims and policyholder dividends excludes:
(i) changes in the policyholder dividend obligation related to NIGL
and NDGL, (ii) inflation-indexed benefit adjustments associated with
contracts backed by inflation-indexed investments and amounts
associated with periodic crediting rate adjustments based on the total
return of a contractually referenced pool of assets, (iii) benefits
and hedging costs related to GMIBs ("GMIB Costs"), and (iv) market
value adjustments associated with surrenders or terminations of
contracts ("Market Value Adjustments");
-
Interest credited to policyholder account balances includes
adjustments for scheduled periodic settlement payments and
amortization of premium on derivatives that are hedges of policyholder
account balances but do not qualify for hedge accounting treatment and
excludes amounts related to net investment income earned on
contractholder-directed unit-linked investments;
-
Amortization of DAC and value of business acquired ("VOBA") excludes
amounts related to: (i) NIGL and NDGL, (ii) GMIB Fees and GMIB Costs
and (iii) Market Value Adjustments;
-
Amortization of negative VOBA excludes amounts related to Market Value
Adjustments;
-
Interest expense on debt excludes certain amounts related to
securitization entities that are VIEs consolidated under GAAP; and
-
Other expenses excludes costs related to: (i) noncontrolling
interests, (ii) implementation of new insurance regulatory
requirements, and (iii) business combinations.
MetLife believes the presentation of operating earnings and operating
earnings available to common shareholders as MetLife measures it for
management purposes enhances the understanding of the company's
performance by highlighting the results of operations and the underlying
profitability drivers of the business. Operating revenues, operating
expenses, operating earnings, operating earnings available to common
shareholders, operating earnings available to common shareholders per
diluted common share, book value per common share, excluding accumulated
other comprehensive income ("AOCI"), and book value per diluted common
share, excluding AOCI, should not be viewed as substitutes for the
following financial measures calculated in accordance with GAAP: GAAP
revenues, GAAP expenses, GAAP income (loss) from continuing operations,
net of income tax, GAAP net income (loss) available to MetLife, Inc.'s
common shareholders, GAAP net income (loss) available to MetLife, Inc.'s
common shareholders per diluted common share, book value per common
share, and book value per diluted common share, respectively.
Reconciliations of these measures to the most directly comparable GAAP
measures are included in the Fourth Quarter 2011 Quarterly Financial
Supplement and/or in the tables that accompany this earnings press
release.
Statistical sales information for life insurance is calculated by
MetLife using the LIMRA International, Inc. definition of sales for core
direct sales, excluding company sponsored internal exchanges,
corporate-owned life insurance, bank-owned life insurance, and private
placement variable universal life insurance. Individual annuities sales
consists of statutory premiums direct and assumed, excluding company
sponsored internal exchanges.
Forward-Looking Statements
This press release may contain or incorporate by reference information
that includes or is based upon forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements give expectations or forecasts of future
events. These statements can be identified by the fact that they do not
relate strictly to historical or current facts. They use words such as
"anticipate," "estimate," "expect," "project," "intend," "plan,"
"believe" and other words and terms of similar meaning in connection
with a discussion of future operating or financial performance. In
particular, these include statements relating to future actions,
prospective services or products, future performance or results of
current and anticipated services or products, sales efforts, expenses,
the outcome of contingencies such as legal proceedings, trends in
operations and financial results.
Any or all forward-looking statements may turn out to be wrong. They can
be affected by inaccurate assumptions or by known or unknown risks and
uncertainties. Many such factors will be important in determining the
actual future results of MetLife, Inc., its subsidiaries and affiliates.
These statements are based on current expectations and the current
economic environment. They involve a number of risks and uncertainties
that are difficult to predict. These statements are not guarantees of
future performance. Actual results could differ materially from those
expressed or implied in the forward-looking statements. Risks,
uncertainties, and other factors that might cause such differences
include the risks, uncertainties and other factors identified in
MetLife, Inc.'s filings with the U.S. Securities and Exchange Commission
(the "SEC"). These factors include: (1) difficult conditions in the
global capital markets; (2) concerns over U.S. fiscal policy and the
trajectory of the national debt of the U.S., as well as rating agency
downgrades of U.S. Treasury securities; (3) increased volatility and
disruption of the capital and credit markets, which may affect our
ability to seek financing or access our credit facilities; (4)
uncertainty about the effectiveness of the U.S. government's programs to
stabilize the financial system, the imposition of fees relating thereto,
or the promulgation of additional regulations; (5) impact of
comprehensive financial services regulation reform on us; (6) exposure
to financial and capital market risk; (7) changes in general economic
conditions, including the performance of financial markets and interest
rates, which may affect our ability to raise capital, generate fee
income and market-related revenue and finance statutory reserve
requirements and may require us to pledge collateral or make payments
related to declines in value of specified assets; (8) potential
liquidity and other risks resulting from our participation in a
securities lending program and other transactions; (9) investment losses
and defaults, and changes to investment valuations; (10) impairments of
goodwill and realized losses or market value impairments to illiquid
assets; (11) defaults on our mortgage loans; (12) the impairment of
other financial institutions that could adversely affect our investments
or business; (13) our ability to address unforeseen liabilities, asset
impairments, loss of key contractual relationships, or rating actions
arising from acquisitions or dispositions, including our acquisition of
American Life Insurance Company and Delaware American Life Insurance
Company (collectively, "ALICO") and to successfully integrate and manage
the growth of acquired businesses with minimal disruption; (14)
uncertainty with respect to the outcome of the closing agreement entered
into with the United States Internal Revenue Service in connection with
the acquisition of ALICO; (15) the dilutive impact on our stockholders
resulting from the issuance of equity securities in connection with the
acquisition of ALICO or otherwise; (16) economic, political, currency
and other risks relating to our international operations, including with
respect to fluctuations of exchange rates; (17) our primary reliance, as
a holding company, on dividends from our subsidiaries to meet debt
payment obligations and the applicable regulatory restrictions on the
ability of the subsidiaries to pay such dividends; (18) downgrades in
our claims paying ability, financial strength or credit ratings; (19)
ineffectiveness of risk management policies and procedures; (20)
availability and effectiveness of reinsurance or indemnification
arrangements, as well as default or failure of counterparties to
perform; (21) discrepancies between actual claims experience and
assumptions used in setting prices for our products and establishing the
liabilities for our obligations for future policy benefits and claims;
(22) catastrophe losses; (23) heightened competition, including with
respect to pricing, entry of new competitors, consolidation of
distributors, the development of new products by new and existing
competitors, distribution of amounts available under U.S. government
programs, and for personnel; (24) unanticipated changes in industry
trends; (25) changes in accounting standards, practices and/or policies;
(26) changes in assumptions related to deferred policy acquisition
costs, deferred sales inducements, value of business acquired or
goodwill; (27) increased expenses relating to pension and postretirement
benefit plans, as well as health care and other employee benefits; (28)
exposure to losses related to variable annuity guarantee benefits,
including from significant and sustained downturns or extreme volatility
in equity markets, reduced interest rates, unanticipated policyholder
behavior, mortality or longevity, and the adjustment for nonperformance
risk; (29) deterioration in the experience of the "closed block"
established in connection with the reorganization of Metropolitan Life
Insurance Company; (30) adverse results or other consequences from
litigation, arbitration or regulatory investigations; (31) inability to
protect our intellectual property rights or claims of infringement of
the intellectual property rights of others; (32) discrepancies between
actual experience and assumptions used in establishing liabilities
related to other contingencies or obligations; (33) regulatory,
legislative or tax changes relating to our insurance, banking,
international, or other operations that may affect the cost of, or
demand for, our products or services, impair our ability to attract and
retain talented and experienced management and other employees, or
increase the cost or administrative burdens of providing benefits to
employees; (34) the effects of business disruption or economic
contraction due to disasters such as terrorist attacks, cyberattacks,
other hostilities, or natural catastrophes, including any related impact
on our disaster recovery systems, cyber- or other information security
systems and management continuity planning; (35) the effectiveness of
our programs and practices in avoiding giving our associates incentives
to take excessive risks; and (36) other risks and uncertainties
described from time to time in MetLife, Inc.'s filings with the SEC.
MetLife, Inc. does not undertake any obligation to publicly correct or
update any forward-looking statement if MetLife, Inc. later becomes
aware that such statement is not likely to be achieved. Please consult
any further disclosures MetLife, Inc. makes on related subjects in
reports to the SEC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
|
Consolidated Statements of Operations (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
For the Years Ended
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
(In millions)
|
|
|
(In millions)
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
|
$
|
9,171
|
|
|
|
$
|
7,215
|
|
|
|
$
|
36,361
|
|
|
|
$
|
27,071
|
|
|
Universal life and investment-type product policy fees
|
|
|
|
1,950
|
|
|
|
|
1,689
|
|
|
|
|
7,806
|
|
|
|
|
6,028
|
|
|
Net investment income
|
|
|
|
4,938
|
|
|
|
|
4,766
|
|
|
|
|
19,606
|
|
|
|
|
17,511
|
|
|
Other revenues
|
|
|
|
654
|
|
|
|
|
647
|
|
|
|
|
2,532
|
|
|
|
|
2,328
|
|
|
Net investment gains (losses):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other-than-temporary impairments on fixed maturity securities
|
|
|
|
(399
|
)
|
|
|
|
(144
|
)
|
|
|
|
(924
|
)
|
|
|
|
(682
|
)
|
|
|
Other-than-temporary impairments on fixed maturity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
transferred to other comprehensive income (loss)
|
|
|
|
(26
|
)
|
|
|
|
31
|
|
|
|
|
(31
|
)
|
|
|
|
212
|
|
|
|
Other net investment gains (losses)
|
|
|
|
(133
|
)
|
|
|
|
29
|
|
|
|
|
88
|
|
|
|
|
62
|
|
|
|
|
Total net investment gains (losses)
|
|
|
|
(558
|
)
|
|
|
|
(84
|
)
|
|
|
|
(867
|
)
|
|
|
|
(408
|
)
|
|
|
Net derivative gains (losses)
|
|
|
|
591
|
|
|
|
|
(1,543
|
)
|
|
|
|
4,824
|
|
|
|
|
(265
|
)
|
|
|
|
Total revenues
|
|
|
|
16,746
|
|
|
|
|
12,690
|
|
|
|
|
70,262
|
|
|
|
|
52,265
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder benefits and claims
|
|
|
|
9,090
|
|
|
|
|
7,482
|
|
|
|
|
35,457
|
|
|
|
|
29,185
|
|
|
Interest credited to policyholder account balances
|
|
|
|
1,499
|
|
|
|
|
1,465
|
|
|
|
|
5,603
|
|
|
|
|
4,919
|
|
|
Policyholder dividends
|
|
|
|
316
|
|
|
|
|
329
|
|
|
|
|
1,446
|
|
|
|
|
1,485
|
|
|
Other expenses
|
|
|
|
4,320
|
|
|
|
|
3,434
|
|
|
|
|
17,730
|
|
|
|
|
12,764
|
|
|
|
|
Total expenses
|
|
|
|
15,225
|
|
|
|
|
12,710
|
|
|
|
|
60,236
|
|
|
|
|
48,353
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before provision for income
tax
|
|
|
|
1,521
|
|
|
|
|
(20
|
)
|
|
|
|
10,026
|
|
|
|
|
3,912
|
|
|
Provision for income tax expense (benefit)
|
|
|
|
394
|
|
|
|
|
(86
|
)
|
|
|
|
3,075
|
|
|
|
|
1,165
|
|
|
Income (loss) from continuing operations, net of income tax
|
|
|
|
1,127
|
|
|
|
|
66
|
|
|
|
|
6,951
|
|
|
|
|
2,747
|
|
|
Income (loss) from discontinued operations, net of income tax
|
|
|
|
25
|
|
|
|
|
19
|
|
|
|
|
20
|
|
|
|
|
39
|
|
|
Net income (loss)
|
|
|
|
1,152
|
|
|
|
|
85
|
|
|
|
|
6,971
|
|
|
|
|
2,786
|
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
|
(4
|
)
|
|
|
|
3
|
|
|
|
|
(10
|
)
|
|
|
|
(4
|
)
|
|
Net income (loss) attributable to MetLife, Inc.
|
|
|
|
1,156
|
|
|
|
|
82
|
|
|
|
|
6,981
|
|
|
|
|
2,790
|
|
|
Less: Preferred stock dividends
|
|
|
|
31
|
|
|
|
|
31
|
|
|
|
|
122
|
|
|
|
|
122
|
|
|
Preferred stock redemption premium (1)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
146
|
|
|
|
|
-
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
1,125
|
|
|
|
$
|
51
|
|
|
|
$
|
6,713
|
|
|
|
$
|
2,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation to Operating Earnings Available to Common
Shareholders (2)
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
1,125
|
|
|
|
$
|
51
|
|
|
|
$
|
6,713
|
|
|
|
$
|
2,668
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments from net income (loss) available to MetLife, Inc.'s
common shareholders to operating
|
|
|
|
|
|
earnings available to common shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(558
|
)
|
|
|
|
(84
|
)
|
|
|
|
(867
|
)
|
|
|
|
(408
|
)
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
591
|
|
|
|
|
(1,543
|
)
|
|
|
|
4,824
|
|
|
|
|
(265
|
)
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(521
|
)
|
|
|
|
(58
|
)
|
|
|
|
(1,641
|
)
|
|
|
|
(914
|
)
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
186
|
|
|
|
|
526
|
|
|
|
|
(845
|
)
|
|
|
|
379
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
25
|
|
|
|
|
19
|
|
|
|
|
20
|
|
|
|
|
39
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interests
|
|
|
|
(4
|
)
|
|
|
|
3
|
|
|
|
|
(10
|
)
|
|
|
|
(4
|
)
|
|
|
Add: Preferred stock redemption premium (1)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
146
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
1,398
|
|
|
|
$
|
1,194
|
|
|
|
$
|
5,358
|
|
|
|
$
|
3,833
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP revenues to operating revenues and GAAP
expenses to operating expenses (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
$
|
16,746
|
|
|
|
$
|
12,690
|
|
|
|
$
|
70,262
|
|
|
|
$
|
52,265
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(558
|
)
|
|
|
|
(84
|
)
|
|
|
|
(867
|
)
|
|
|
|
(408
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
591
|
|
|
|
|
(1,543
|
)
|
|
|
|
4,824
|
|
|
|
|
(265
|
)
|
|
Less: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
|
|
|
|
-
|
|
|
|
|
(5
|
)
|
|
|
|
14
|
|
|
|
|
1
|
|
|
Less: Other adjustments to revenues
|
|
|
|
308
|
|
|
|
|
560
|
|
|
|
|
907
|
|
|
|
|
1,494
|
|
|
Total operating revenues
|
|
|
$
|
16,405
|
|
|
|
$
|
13,762
|
|
|
|
$
|
65,384
|
|
|
|
$
|
51,443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
|
$
|
15,225
|
|
|
|
$
|
12,710
|
|
|
|
$
|
60,236
|
|
|
|
$
|
48,353
|
|
|
Less: Adjustments related to net investment gains (losses) and net
derivative gains (losses)
|
|
|
|
7
|
|
|
|
|
(138
|
)
|
|
|
|
572
|
|
|
|
|
125
|
|
|
Less: Other adjustments to expenses
|
|
|
|
822
|
|
|
|
|
751
|
|
|
|
|
1,990
|
|
|
|
|
2,284
|
|
|
Total operating expenses
|
|
|
$
|
14,396
|
|
|
|
$
|
12,097
|
|
|
|
$
|
57,674
|
|
|
|
$
|
45,944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
|
For the Years Ended
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Earnings Per Common Share Calculation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
per common share - diluted
|
|
|
$
|
1.06
|
|
|
|
$
|
0.05
|
|
|
|
$
|
6.29
|
|
|
|
$
|
3.00
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(0.52
|
)
|
|
|
|
(0.08
|
)
|
|
|
|
(0.81
|
)
|
|
|
|
(0.46
|
)
|
|
Less: Net derivative gains (losses)
|
|
|
|
0.55
|
|
|
|
|
(1.52
|
)
|
|
|
|
4.52
|
|
|
|
|
(0.30
|
)
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(0.48
|
)
|
|
|
|
(0.07
|
)
|
|
|
|
(1.54
|
)
|
|
|
|
(1.02
|
)
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
0.18
|
|
|
|
|
0.52
|
|
|
|
|
(0.79
|
)
|
|
|
|
0.43
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
0.02
|
|
|
|
|
0.02
|
|
|
|
|
0.02
|
|
|
|
|
0.04
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(0.01
|
)
|
|
|
|
-
|
|
|
Add: Preferred stock redemption premium
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
0.14
|
|
|
|
|
-
|
|
|
Operating earnings available to common shareholders per common share
- diluted
|
|
|
$
|
1.31
|
|
|
|
$
|
1.18
|
|
|
|
$
|
5.02
|
|
|
|
$
|
4.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - diluted (1)
|
|
|
|
1,066.3
|
|
|
|
|
1,014.9
|
|
|
|
|
1,068.1
|
|
|
|
|
889.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
Book Value Per Common Share Calculation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book value per common share - (actual common shares outstanding) (3)
|
|
|
|
|
|
|
|
|
$
|
54.59
|
|
|
|
$
|
44.18
|
|
|
Less: Accumulated other comprehensive income (loss) per common share
|
|
|
|
|
|
|
5.57
|
|
|
|
|
0.95
|
|
|
Book value per common share, excluding accumulated other
comprehensive income (loss) - (actual common shares outstanding)
(3)
|
|
|
|
|
|
|
|
|
$
|
49.02
|
|
|
|
$
|
43.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares outstanding, end of year (1)
|
|
|
|
|
|
|
|
|
|
1,058.0
|
|
|
|
|
1054.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.
|
|
Reconciliations of Net Income (Loss) Available to Common
Shareholders to Operating Earnings Available to Common Shareholders
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Years Ended
|
|
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
|
|
2011
|
|
|
2010
|
|
|
2011
|
|
|
2010
|
|
|
|
|
|
|
(In millions)
|
|
|
(In millions)
|
|
Total U.S. Business Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
1,192
|
|
|
|
$
|
406
|
|
|
|
$
|
5,607
|
|
|
|
$
|
3,490
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(52
|
)
|
|
|
|
129
|
|
|
|
|
151
|
|
|
|
|
411
|
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
823
|
|
|
|
|
(921
|
)
|
|
|
|
3,950
|
|
|
|
|
287
|
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(381
|
)
|
|
|
|
37
|
|
|
|
|
(811
|
)
|
|
|
|
(485
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(134
|
)
|
|
|
|
264
|
|
|
|
|
(1,150
|
)
|
|
|
|
(83
|
)
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
(2
|
)
|
|
|
|
5
|
|
|
|
|
61
|
|
|
|
|
19
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(6
|
)
|
|
|
|
2
|
|
|
|
|
(3
|
)
|
|
|
|
3
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
932
|
|
|
|
$
|
894
|
|
|
|
$
|
3,403
|
|
|
|
$
|
3,344
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
566
|
|
|
|
$
|
(34
|
)
|
|
|
$
|
2,664
|
|
|
|
$
|
1,371
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(2
|
)
|
|
|
|
25
|
|
|
|
|
53
|
|
|
|
|
103
|
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
160
|
|
|
|
|
(496
|
)
|
|
|
|
1,849
|
|
|
|
|
215
|
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
84
|
|
|
|
|
(57
|
)
|
|
|
|
(125
|
)
|
|
|
|
(244
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(85
|
)
|
|
|
|
183
|
|
|
|
|
(623
|
)
|
|
|
|
(28
|
)
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
(1
|
)
|
|
|
|
2
|
|
|
|
|
36
|
|
|
|
|
4
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
1
|
|
|
|
|
-
|
|
|
|
|
1
|
|
|
|
|
-
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
411
|
|
|
|
$
|
309
|
|
|
|
$
|
1,475
|
|
|
|
$
|
1,321
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
248
|
|
|
|
$
|
10
|
|
|
|
$
|
1,421
|
|
|
|
$
|
792
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
12
|
|
|
|
|
43
|
|
|
|
|
84
|
|
|
|
|
139
|
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
527
|
|
|
|
|
(392
|
)
|
|
|
|
1,747
|
|
|
|
|
235
|
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(496
|
)
|
|
|
|
23
|
|
|
|
|
(777
|
)
|
|
|
|
(381
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(14
|
)
|
|
|
|
109
|
|
|
|
|
(368
|
)
|
|
|
|
(4
|
)
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
1
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(3
|
)
|
|
|
|
1
|
|
|
|
|
(2
|
)
|
|
|
|
1
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
216
|
|
|
|
$
|
228
|
|
|
|
$
|
733
|
|
|
|
$
|
803
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Benefit Funding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
298
|
|
|
|
$
|
354
|
|
|
|
$
|
1,432
|
|
|
|
$
|
1,032
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(63
|
)
|
|
|
|
65
|
|
|
|
|
23
|
|
|
|
|
176
|
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
138
|
|
|
|
|
(39
|
)
|
|
|
|
366
|
|
|
|
|
(162
|
)
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
31
|
|
|
|
|
71
|
|
|
|
|
91
|
|
|
|
|
140
|
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
(35
|
)
|
|
|
|
(28
|
)
|
|
|
|
(166
|
)
|
|
|
|
(54
|
)
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
(1
|
)
|
|
|
|
3
|
|
|
|
|
25
|
|
|
|
|
14
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(4
|
)
|
|
|
|
1
|
|
|
|
|
(2
|
)
|
|
|
|
2
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
224
|
|
|
|
$
|
283
|
|
|
|
$
|
1,091
|
|
|
|
$
|
920
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto & Home:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
80
|
|
|
|
$
|
76
|
|
|
|
$
|
90
|
|
|
|
$
|
295
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
1
|
|
|
|
|
(4
|
)
|
|
|
|
(9
|
)
|
|
|
|
(7
|
)
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
(2
|
)
|
|
|
|
6
|
|
|
|
|
(12
|
)
|
|
|
|
(1
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
7
|
|
|
|
|
3
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
81
|
|
|
|
$
|
74
|
|
|
|
$
|
104
|
|
|
|
$
|
300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total International Operations: (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
214
|
|
|
|
$
|
(182
|
)
|
|
|
$
|
1,933
|
|
|
|
$
|
(126
|
)
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(337
|
)
|
|
|
|
(21
|
)
|
|
|
|
(837
|
)
|
|
|
|
(289
|
)
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
(230
|
)
|
|
|
|
(648
|
)
|
|
|
|
985
|
|
|
|
|
(491
|
)
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(5
|
)
|
|
|
|
(14
|
)
|
|
|
|
(403
|
)
|
|
|
|
(427
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
189
|
|
|
|
|
187
|
|
|
|
|
15
|
|
|
|
|
274
|
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
27
|
|
|
|
|
13
|
|
|
|
|
(44
|
)
|
|
|
|
22
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
-
|
|
|
|
|
1
|
|
|
|
|
(5
|
)
|
|
|
|
(5
|
)
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
570
|
|
|
|
$
|
302
|
|
|
|
$
|
2,212
|
|
|
|
$
|
780
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
254
|
|
|
|
$
|
2
|
|
|
|
$
|
1,185
|
|
|
|
$
|
2
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(106
|
)
|
|
|
|
(9
|
)
|
|
|
|
(221
|
)
|
|
|
|
(9
|
)
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
(28
|
)
|
|
|
|
(144
|
)
|
|
|
|
200
|
|
|
|
|
(144
|
)
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
23
|
|
|
|
|
12
|
|
|
|
|
38
|
|
|
|
|
12
|
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
41
|
|
|
|
|
49
|
|
|
|
|
(3
|
)
|
|
|
|
49
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
2
|
|
|
|
|
-
|
|
|
|
|
5
|
|
|
|
|
-
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
326
|
|
|
|
$
|
94
|
|
|
|
$
|
1,176
|
|
|
|
$
|
94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other International Regions: (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
(40
|
)
|
|
|
$
|
(184
|
)
|
|
|
$
|
748
|
|
|
|
$
|
(128
|
)
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(231
|
)
|
|
|
|
(12
|
)
|
|
|
|
(616
|
)
|
|
|
|
(280
|
)
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
(202
|
)
|
|
|
|
(504
|
)
|
|
|
|
785
|
|
|
|
|
(347
|
)
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(28
|
)
|
|
|
|
(26
|
)
|
|
|
|
(441
|
)
|
|
|
|
(439
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
148
|
|
|
|
|
138
|
|
|
|
|
18
|
|
|
|
|
225
|
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
27
|
|
|
|
|
13
|
|
|
|
|
(44
|
)
|
|
|
|
22
|
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
(2
|
)
|
|
|
|
1
|
|
|
|
|
(10
|
)
|
|
|
|
(5
|
)
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
244
|
|
|
|
$
|
208
|
|
|
|
$
|
1,036
|
|
|
|
$
|
686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate & Other: (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.'s common shareholders
|
|
|
$
|
(281
|
)
|
|
|
$
|
(173
|
)
|
|
|
$
|
(827
|
)
|
|
|
$
|
(696
|
)
|
|
|
|
Less: Net investment gains (losses)
|
|
|
|
(169
|
)
|
|
|
|
(192
|
)
|
|
|
|
(181
|
)
|
|
|
|
(530
|
)
|
|
|
|
Less: Net derivative gains (losses)
|
|
|
|
(2
|
)
|
|
|
|
26
|
|
|
|
|
(111
|
)
|
|
|
|
(61
|
)
|
|
|
|
Less: Other adjustments to continuing operations
|
|
|
|
(135
|
)
|
|
|
|
(81
|
)
|
|
|
|
(427
|
)
|
|
|
|
(2
|
)
|
|
|
|
Less: Provision for income tax (expense) benefit
|
|
|
|
131
|
|
|
|
|
75
|
|
|
|
|
290
|
|
|
|
|
188
|
|
|
|
|
Less: Income (loss) from discontinued operations, net of income tax
|
|
|
|
-
|
|
|
|
|
1
|
|
|
|
|
3
|
|
|
|
|
(2
|
)
|
|
|
|
Add: Net income (loss) attributable to noncontrolling interest
|
|
|
|
2
|
|
|
|
|
-
|
|
|
|
|
(2
|
)
|
|
|
|
(2
|
)
|
|
|
|
Add: Preferred stock redemption premium (1)
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
146
|
|
|
|
|
-
|
|
|
|
|
Operating earnings available to common shareholders
|
|
|
$
|
(104
|
)
|
|
|
$
|
(2
|
)
|
|
|
$
|
(257
|
)
|
|
|
$
|
(291
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
In connection with the financing of the acquisition of American
Life Insurance Company and Delaware American Life Insurance Company
in November 2010, MetLife, Inc. issued to AM Holdings LLC (formerly
known as ALICO Holdings LLC)("AM Holdings") 6,857,000 shares of
convertible preferred stock. For purposes of the December 31, 2010
common share and weighted average common share calculations, the
convertible preferred stock was treated as 68,570,000 shares of
common stock. On March 8, 2011, MetLife, Inc. issued 68,570,000
shares of common stock for net proceeds of $3.0 billion, which were
used to repurchase and cancel the 6,857,000 shares of convertible
preferred stock held by AM Holdings, resulting in a preferred stock
redemption premium of $146 million.
|
|
|
|
|
|
(2)
|
|
Certain amounts in the prior periods have been reclassified to
conform with the current period segment presentation. During the
fourth quarter of 2011, MetLife, Inc. began reporting certain
operations of MetLife Bank, National Association and insurance
operations in the Caribbean Region, Panama and Costa Rica as
Divested Businesses.
|
|
|
|
|
|
(3)
|
|
MetLife, Inc.'s common equity excludes $2,043 million of equity
related to preferred stock.
|

[ Back To TMCnet.com's Homepage ]
|